Matthew G. Bursavich
0000-0003-4934-7323
Publication & Citation Trends
Most Cited Works
Publications
52 total
Tu1738 REAL-TIME INHIBITION OF INTEGRIN α4β7 BY A SMALL MOLECULE INHIBITOR IMPAIRS B LYMPHOCYTE ADHESION IN MURINE PEYER'S PATCHES
Cited by 0
Semantic Scholar
The Discovery of MORF-627, a Highly Selective Conformationally-Biased Zwitterionic Integrin αvβ6 Inhibitor for Fibrosis.
Cited by 3
Semantic Scholar
Sa1761 PREDICTIVE TRANSLATIONAL BLOOD BIOMARKER DYNAMICS OF SMALL MOLECULE α4β7 INHIBITION IN NONHUMAN PRIMATE
Cited by 0
Semantic Scholar
P102 A small molecule selective integrin α4β7 inhibitor demonstrates efficacy in a chronic model of Inflammatory Bowel Disease OA
Cited by 1
Semantic Scholar
Su1121: PHARMACOLOGIC INHIBITION OF INTEGRIN α4β7 BY SMALL MOLECULE INHIBITOR ARRESTS B LYMPHOCYTE TRAFFICKING TO MURINE GUT-ASSOCIATED LYMPHOID TISSUES
Cited by 0
Semantic Scholar
The development of a gut-specific immune response to an oral antigen is dependent on α4β7 mediated lymphocyte trafficking
Cited by 0
Semantic Scholar
DOP50 Oral α4β7 integrin inhibitor MORF-057 demonstrates exposure driven biomarker response in non-human primates OA
Cited by 0
Semantic Scholar
Discovery of the Oxadiazine FRM-024: A Potent CNS-Penetrant Gamma Secretase Modulator PDF
Cited by 10
OpenAlex
Research Topics
Chemical Synthesis and Analysis
(17)
Peptidase Inhibition and Analysis
(9)
Computational Drug Discovery Methods
(7)
Cell Adhesion Molecules Research
(6)
Alzheimer's disease research and treatments
(5)
Frequent Co-Authors
Affiliations
Louisiana State University
University of Wisconsin–Madison
Myriad (Germany)
Pfizer (United States)
Pearl River Community College